Clinical Trial Update: Intranasal Oxytocin for the Treatment of Alcohol Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial of intranasal oxytocin for alcohol use disorder has completed and results were posted on July 23, 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Misuse
• Alcohol Use Disorder

Drugs mentioned

• Oxytocin (intranasal) (oxytocin)

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcohol Use Disorder, Alcohol Misuse | Phase 2 | Status: COMPLETED | Results posted: 2025-07-23